Concerns & Risks -- 5/10
| Metric | AMAT | ASML | LRCX | KLAC | TEL |
|---|---|---|---|---|---|
| Forward P/E (NTM) | ~38x | ~45x | ~45x | ~40x | ~27x |
| EV/EBITDA (NTM) | ~25x | ~28x | ~20x | ~26x | ~17x |
| Quarter | China Rev ($M) | % of Total | Trend |
|---|---|---|---|
| FQ3 FY25 | $2,548 | 34.9% | Peak quarter |
| FQ4 FY25 | $1,964 | 28.9% | Sharp step-down |
| FQ1 FY26 | $2,095 | 29.9% | Modest rebound |
| FQ2 FY26 | $2,087 | 26.4% | Declining toward mid-20s |
| Catalyst | Timing | Detail |
|---|---|---|
| DRAM + Packaging Master Class | June 25, 2026 | Deep-dive on HBM, advanced packaging roadmap |
| FQ3 FY26 Earnings | ~Aug 2026 | Guide +23% rev / +36% EPS YoY |
| EPIC Center Unveiling | Oct 12, 2026 | TSMC, Samsung, SK Hynix, Micron founding partners |
| SEMICON West | Oct 13, 2026 | Industry showcase, product announcements |
| NEXX Acquisition | Pending | Panel-level packaging capability |
| Packaging Revenue | CY2026 | >50% growth expected |
| Risk Factor | Detail | Severity |
|---|---|---|
| Export Control Revenue Loss | $600-710M FY2026 China revenue loss from expanded export rules | HIGH |
| MATCH Legislation | Bipartisan MATCH-style legislation pending -- broader equipment controls | HIGH |
| Huawei / Co-Mingled Fab Risk | Restriction risk on sales to fabs with Huawei-adjacent production | MEDIUM |
| BIS Settlement ($252.5M) | Resolved, but signals heightened regulatory attention on AMAT specifically | RESOLVED |
Score of 5/10 reflects a mixed risk profile where meaningful secular tailwinds are offset by elevated regulatory exposure.
Positives: Cheapest major WFE peer on forward P/E (~38x vs ~42x avg) (+). Dense near-term catalyst slate -- EPIC Center, DRAM Master Class, SEMICON West all in H2 2026 (+). Non-GAAP EPS growth +20% YoY with guide calling +36% in FQ3 -- valuation de-rating rapidly (+). #1 position across GAA, packaging, and backside power delivery (+). Packaging revenue >50% CY26 growth (+). 8-quarter customer visibility provides earnings durability (+).
Negatives: China at ~24% of revenue is far above 10% regulatory comfort threshold (-). $600-710M FY2026 revenue at risk from export controls (-). Bipartisan MATCH legislation could broaden restrictions further (-). BIS settlement ($252.5M) signals AMAT-specific regulatory scrutiny (-). Customer concentration in TSMC and Samsung creates binary risk (-). WFE cyclicality could interrupt the AI supercycle narrative (-).
Net: Upgraded from 4 to 5 as China exposure has declined from ~35% to ~24%, EPS growth has re-accelerated with strong FQ3 guidance, and the catalyst slate has thickened. The discount to peers is narrowing for the right reasons. Key watch items: (1) China mix continuing below 25%, (2) regulatory clarity on MATCH legislation, (3) EPIC Center customer commitments at Oct unveiling.